ARCHIVES

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Tempero, Johnson To Lead ASCO

March 28, 2003

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

January 26, 2001

Receipt Dates Clarified For AIDS-Cancers PA

July 4, 1997

DCE Board Approves Recompetitions, Program Announcement For Research On Fish

July 7, 1989

ASCO Annual Meeting: NCI goals: Expand Clinical Trials, Build Informatics Network

May 30, 1997

Foundation Gives Duke $2M For Brain Tumor Research.

March 23, 2001